Anonymous
Guest
Anonymous
Guest
OMG I cringe at the thought of being acquired by Actavis and Forest. Our legacy as a top notch pharma company has ended.
OMG I cringe at the thought of being acquired by Actavis and Forest. Our legacy as a top notch pharma company has ended.
Well said - bravo!Be real - Allergan was never a top-notch pharma company. It was only successful for milking the hell out of a few minor medications, while living off of the Botox cash cow. Multi-millions pissed away on research and IP with nothing to show.
I was there, and it was headed for a huge trainwreck. Thank your lucky stars for Actavis!
Be real - Allergan was never a top-notch pharma company. It was only successful for milking the hell out of a few minor medications, while living off of the Botox cash cow. Multi-millions pissed away on research and IP with nothing to show.
I was there, and it was headed for a huge trainwreck. Thank your lucky stars for Actavis!
OMG I cringe at the thought of being acquired by Actavis and Forest. Our legacy as a top notch pharma company has ended.
No idea. Stock growth is for greedy investors, and doesn't reflect the medical value that a top-notch drug company creates.What was the "train wreck" it is was heading toward?
Restasis coming off patent, biosimilars pushing out Botox, lack of new significant compounds emerging from discovery or progressing through development. It was looking pretty grim.
What's your definition of a "top-notch" company?
Companies that produce critical drugs for serious illnesses such as cancer, diabetes, heart disease, epilepsy, MS, infections, etc. etc. etc.
Novartis, Genentech, Biogen-Idec, Bayer, GSK and others come to mind. Most of Allergan's drugs were repurposed old drugs (such as cyclosporin, originally developed for transplant rejection).
Drug development efforts were focused on creating combinations of old drugs, which isn't an innovative strategy or effective with the payers that would require using the off-patent generics. This is now way to run a pharmaceutical business, but I'll give DP credit for milking this cow dry.
What was Allergan R&D ROI over the last 15 years?
Not much, since no new chemical entities were developed over that time. All drugs were the result of repurposing. It worked to bring in some big cash, but that party has to end.
How much did its stock grow since Alphagan?
No idea. Stock growth is for greedy investors, and doesn't reflect the medical value that a top-notch drug company creates.
Exactly how much medical value is there in Botox?
As soon as the merger is complete, everything will have to be adapted to meet the Forest CIA. Inav, dinner programs, coaching guides, everything. I worked at Forest then came to Allergan and I am dry heaving just thinking about it. Every coaching guide has a report that every DM needs to sign off on that they "didn't hear anything non compliant". Dinner programs are all audited and many have 3rd party compliance people in site. They record and write down everything then they grill you later on on every detail. Your inav will have a record of everything you present and to whom. There are traps that try and catch you, like presenting data to the wrong specialty you have set the call up for, ect. Slides that were approved for psychs couldn't be used for primary care, ect but we're in the digital video aid to try and catch people screwing up. Your whole call file and presentations get routinely audited. It was a nightmare, and it is coming.
No idea. Stock growth is for greedy investors, and doesn't reflect the medical value that a top-notch drug company creates.
No idea. Stock growth is for greedy investors, and doesn't reflect the medical value that a top-notch drug company creates.
As soon as the merger is complete, everything will have to be adapted to meet the Forest CIA. Inav, dinner programs, coaching guides, everything. I worked at Forest then came to Allergan and I am dry heaving just thinking about it. Every coaching guide has a report that every DM needs to sign off on that they "didn't hear anything non compliant". Dinner programs are all audited and many have 3rd party compliance people in site. They record and write down everything then they grill you later on on every detail. Your inav will have a record of everything you present and to whom. There are traps that try and catch you, like presenting data to the wrong specialty you have set the call up for, ect. Slides that were approved for psychs couldn't be used for primary care, ect but we're in the digital video aid to try and catch people screwing up. Your whole call file and presentations get routinely audited. It was a nightmare, and it is coming.
Repeat after me: IT'S NOT A MERGER! It's a BUYOUT.
Be real - Allergan was never a top-notch pharma company. It was only successful for milking the hell out of a few minor medications, while living off of the Botox cash cow. Multi-millions pissed away on research and IP with nothing to show.
I was there, and it was headed for a huge trainwreck. Thank your lucky stars for Actavis!
Legacy Actavis rep here, once we merged with Forest we became Forest. Their rules, their managers. If you are black, older female, Latino, or have a voice about anything you will have a target on your back. Most Actavis reps have been fired or managed out. This is fair warning. Forest management is the bottom of the barrel and they want young, dumb, reps who will literally kiss their butt. Kiss up, shut your mouth, and drink the cool aide or they will make your life and career miserable. If your manager is talking about himself, his opinion, his life, and you interrupt him to discuss something about business; don't do it. Listen attentively and make him think you suck and he is greatest. Mark my words. Welcome to Forest! Actavis was not like this.